Impact of CD3 expression on outcome in pediatric anaplastic large cell lymphoma

Impact of CD3 expression on outcome in pediatric anaplastic large cell lymphoma

BackgroundAnaplastic large cell lymphoma (ALCL) constitutes 10-15% of childhood non-Hodgkin lymphoma. EFS is 70% and currently 80% with the additional of targeted agents such as CD30 directed conjugated monoclonal antibody brentuximab or ALK inhibitors such as crizotinib. Expression of CD3, a T-cell...

Full description

Saved in:

Bibliographic Details
Main Authors:	Ahmed Salah, Hanafy Hafez, Samah Semary, Eman Naguib Khorshed, Sonia Soliman, Iman Zaky, Shahenda M. Shahin, Leslie Lehmann, Alaa ElHaddad
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2025-05-01
Series:	Frontiers in Oncology
Subjects:	CD3 survival pediatric anaplastic large cell lymphoma ALK outcome
Online Access:	https://www.frontiersin.org/articles/10.3389/fonc.2025.1569370/full
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Corrigendum: Impact of CD3 expression on outcome in pediatric anaplastic large cell lymphoma
by: Ahmed Salah, et al.
Published: (2025-06-01)

Comprehensive study of anaplastic large cell lymphoma: clinicopathological features from Indonesia
by: Agnes Stephanie Harahap, et al.
Published: (2025-07-01)

An Isolated Cutaneous Relapse in a Known Case of Systemic ALK-Positive Anaplastic Large Cell Lymphoma: A Rare Case Report with Review of Literature
by: Monisha Shetty, et al.

MOLECULAR BIOLOGICAL CHARACTERISTICS OF ALK-POSITIVE ANAPLASTIC LARGE CELL LYMPHOMA
by: E. V. Chernyshova, et al.
Published: (2017-01-01)

ALK-negative anaplastic large-cell lymphoma diagnosed on liver biopsy in a child presenting with nonresolving pyrexia
by: Aanchal Kakkar, et al.
Published: (2019-01-01)

Anaplastic lymphoma kinase-positive inflammatory myofibroblastic tumor of the breast: a case report and review of the literature
by: Yasutaka Kawakita, et al.
Published: (2023-09-01)

Primary bone ALK-positive anaplastic large cell lymphoma presented as a giant extraskeletal mass with coagulation necrosis
by: Shuji Nagata, et al.
Published: (2025-09-01)

PRIMARY PALATAL ALK-NEGATIVE ANAPLASTIC LARGE CELL LYMPHOMA: RARITY TREATED SUCCESSFULLY WITH BRENTUXIMAB VEDOTIN
by: Müjgan Çözeli, et al.
Published: (2024-12-01)

Overcoming Resistance in Relapsed Anaplastic Large-Cell Lymphoma, ALK-Positive (Literature Review and Clinical Experience)
by: YuE Vinogradova, et al.
Published: (2019-03-01)

PTPN2 Inhibition Disrupts Mitochondrial Renewal and Blocks TFRC‐Mediated Mitophagy to Exert Anti‐Tumor Activities in ALK‐Positive Anaplastic Large Cell Lymphoma
by: Wei‐Ting Wang, et al.
Published: (2025-08-01)

Age and smoking intensity in non-small cell lung cancer patients with the anaplastic lymphoma kinase fusion gene
by: Yosuke Maezawa, et al.
Published: (2025-03-01)

A Rare Case of Anaplastic Lymphoma Kinase-negative Anaplastic Large Cell Lymphoma Presenting as Right Heart Failure
by: U. Harikishore, et al.
Published: (2025-01-01)

The Use of Anaplastic Lymphoma Kinase Inhibitors in Non-Small-Cell Lung Cancer Treatment—Literature Review
by: Anita Gorzelak-Magiera, et al.
Published: (2024-10-01)

Anti-ALK autoantibodies in patients with ALK-positive Non-Small Cell Lung Cancer (NSCLC): A monocentric experience
by: Claudia Parisi, et al.
Published: (2024-12-01)

Ensartinib in a primary pulmonary ALK-rearranged mesenchymal neoplasm harboring a novel HMBOX1::ALK fusion: a case report and literature review
by: Qi Liang, et al.
Published: (2025-05-01)

COMBINED CHEMOTHERAPY INCLUDING PROCARBAZINE (NATULAN) IN THE TREATMENT OF ANAPLASTIC OLIGODENDROGLIOMAS
by: D. R. Naskhletashvili, et al.
Published: (2015-04-01)

Prevalence and prognostic impact of BRAF V600E mutation and CDKN2A deletion in pediatric high-grade glioma
by: Soha Karim, et al.
Published: (2025-08-01)

New opportunities for preoperative diagnosis of anaplastic thyroid cancer
by: S. A. Lukyanov, et al.
Published: (2021-04-01)

Single‐center study to determine the safety and efficacy of CT‐707 in Chinese patients with advanced anaplastic lymphoma kinase‐rearranged non‐small‐cell lung cancer
by: Peng Song, et al.
Published: (2020-05-01)

An Anaplastic Lymphoma Kinase-positive Inflammatory Myofibroblastic Tumor with Rapidly Acquired Resistance to First-line Anaplastic Lymphoma Kinase Inhibitor: A Case and Literature Review
by: Shu-Cheng Wu, et al.
Published: (2024-01-01)

Recurrent primary pulmonary anaplastic B-cell lymphoma in a 35-year-old patient treated with radical resection: A case report.
by: George Bashour, et al.
Published: (2025-03-01)

Regressed Papillary Thyroid Carcinoma with Anaplastic Transformation into Lymph Node Metastasis: Case Report with Review of the Literature
by: Bozidar Kovacevic, et al.
Published: (2025-02-01)

Spontaneous pneumothorax caused by an inflammatory myofibroblastic tumor-like lesion in a 14-year-old girl: a case report
by: Hisayuki Miyagi, et al.
Published: (2020-05-01)

Ectopic Solitary Cortical Anaplastic Ependymoma in a Child: A Rare Entity with Short Illustrative Review
by: Sachin Guthe, et al.
Published: (2017-11-01)

Modern Aspects of Diagnosis and Treatment of Anaplastic Large Cell Lymphoma in Children (Literature Review)
by: AS Levashov, et al.
Published: (2016-04-01)

Primary Breast Anaplastic Large-Cell Lymphoma
by: Min-Hong Wang, et al.
Published: (2023-10-01)

Trends in Real-World Clinical Outcomes of Patients with Anaplastic Lymphoma Kinase (ALK) Rearranged Non-Small Cell Lung Cancer (NSCLC) Receiving One or More ALK Tyrosine Kinase Inhibitors (TKIs): A Cohort Study in Ontario, Canada
by: Lara Chayab, et al.
Published: (2024-12-01)

Anaplastic meningioma to supraclavicular lymph node with malignant B cell lymphoma: A rare case report
by: Shrinjay Vyas, et al.
Published: (2025-06-01)

Anaplastic Large Cell Lymphoma with Generalized Skin Lesion in Childhood: Clinical Case
by: Timur T. Valiev, et al.
Published: (2020-12-01)

Targeted therapy of anaplastic thyroid cancer
by: P. A. Nikiforovich, et al.
Published: (2023-03-01)

Clinical Outcomes of Crizotinib Readministration in Patients with Nonsmall Cell Lung Cancer with Anaplastic Lymphoma Kinase Rearrangement: Case Report and Review of Literature
by: Prasant Kumar Parida

Conversion surgery after lenvatinib treatment for anaplastic thyroid carcinoma: a case report
by: Haruhiko Yamazaki, et al.
Published: (2023-03-01)

Case Report: Remarkable and sustained remission of an anaplastic thyroid carcinoma patient to the combined treatment of multimodal radiotherapy, anlotinib and toripalimab
by: Yurou Xing, et al.
Published: (2025-05-01)

Differentiated, immunobased approach of anaplastic large cell lymphoma treatment in children and adolescents: literature review and protocol ALCL-NII DOG-2003 results
by: A. S. Volkova, et al.
Published: (2023-05-01)

Anaplastic (undifferentiated) carcinoma of pancreas, an uncommon variant: Diagnosed on endoscopic-guided fine needle aspiration
by: Md Ali Osama, et al.
Published: (2023-07-01)

Successful treatment of post chemotherapy esophageal cicatricial atresia in a pediatric patient with anaplastic large cell lymphoma through minimally invasive esophagectomy: a case report
by: Yuto Hozaka, et al.
Published: (2021-02-01)

Anaplastic thyroid cancer: current capabilities of an oncologist
by: A. L. Pylev, et al.
Published: (2023-06-01)

Correction: Case Report: Remarkable and sustained remission of an anaplastic thyroid carcinoma patient to the combined treatment of multimodal radiotherapy, anlotinib and toripalimab
by: Yurou Xing, et al.
Published: (2025-07-01)

SYSTEMATIC REVIEW: ANAPLASTIC LARGE CELL LYMPHOMA FOLLOWING BREAST IMPLANT SURGERY
by: Kezia Eveline, et al.
Published: (2023-06-01)

Response to neoadjuvant paclitaxel predicts survival in anaplastic thyroid carcinoma
by: Haruhiko Yamazaki, et al.
Published: (2023-02-01)